CY1107671T1 - Νεα συνθεση γαλακτοολιγοσακχαριτη και η παρασκευη της - Google Patents

Νεα συνθεση γαλακτοολιγοσακχαριτη και η παρασκευη της

Info

Publication number
CY1107671T1
CY1107671T1 CY20071100783T CY071100783T CY1107671T1 CY 1107671 T1 CY1107671 T1 CY 1107671T1 CY 20071100783 T CY20071100783 T CY 20071100783T CY 071100783 T CY071100783 T CY 071100783T CY 1107671 T1 CY1107671 T1 CY 1107671T1
Authority
CY
Cyprus
Prior art keywords
lactalologosakharite
preparation
new composition
intestine
growth
Prior art date
Application number
CY20071100783T
Other languages
English (en)
Inventor
Anthony Graham Wynne
Glenn Gibson
Jacek Witold Slupinski
Georgios Tzortzis
Original Assignee
Clasado Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33568264&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1107671(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0315266A external-priority patent/GB0315266D0/en
Priority claimed from GB0325224A external-priority patent/GB0325224D0/en
Priority claimed from GB0405837A external-priority patent/GB0405837D0/en
Application filed by Clasado Inc. filed Critical Clasado Inc.
Publication of CY1107671T1 publication Critical patent/CY1107671T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)

Abstract

Νέα στελέχη Bifidobacterium bifidum ικανά να παράγουν μία νέα ενζυματική δράση γαλακτοσιδάσης η οποία μετατρέπει τη λακτόζη σε ένα νέο μίγμα γαλακτοολιγοσακχαρίτων. Το μίγμα των ολιγοσακχαριτών μπορεί να ενσωματωθεί σε πολυάριθμα προϊόντα διατροφής ή ζωοτροφές για τη βελτίωση της υγείας του εντέρου δια παραγωγής της αναπτύξεως δισχιδοβακτηρίων στο έντερο και καταστολής της αναπτύξεως της παθογόνου μικροχλωρίδας.
CY20071100783T 2003-06-30 2007-06-13 Νεα συνθεση γαλακτοολιγοσακχαριτη και η παρασκευη της CY1107671T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0315266A GB0315266D0 (en) 2003-06-30 2003-06-30 Novel galactooligosaccharide composition and the preparation thereof
GB0325224A GB0325224D0 (en) 2003-10-29 2003-10-29 Novel galactooligosaccharide composition and the preparation thereof
GB0405837A GB0405837D0 (en) 2004-03-16 2004-03-16 Novel Galactooligosaccharide composition and the preparation thereof
EP04743163.0A EP1644482B2 (en) 2003-06-30 2004-06-30 Novel galactooligosaccharide composition and the preparation thereof

Publications (1)

Publication Number Publication Date
CY1107671T1 true CY1107671T1 (el) 2013-04-18

Family

ID=33568264

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100783T CY1107671T1 (el) 2003-06-30 2007-06-13 Νεα συνθεση γαλακτοολιγοσακχαριτη και η παρασκευη της

Country Status (22)

Country Link
US (1) US7883874B2 (el)
EP (1) EP1644482B2 (el)
JP (2) JP4384656B2 (el)
KR (1) KR100857500B1 (el)
AT (1) ATE360682T1 (el)
AU (1) AU2004254110B2 (el)
BR (1) BRPI0408911B1 (el)
CA (1) CA2520043C (el)
CY (1) CY1107671T1 (el)
DE (1) DE602004006133T3 (el)
DK (1) DK1644482T4 (el)
ES (1) ES2284028T5 (el)
GB (1) GB2412380B (el)
HK (1) HK1077323A1 (el)
IL (1) IL172553A (el)
MX (1) MXPA05010349A (el)
NO (1) NO335413B1 (el)
NZ (1) NZ542482A (el)
PL (1) PL1644482T5 (el)
PT (1) PT1644482E (el)
RU (1) RU2313572C2 (el)
WO (1) WO2005003329A1 (el)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1644482E (pt) * 2003-06-30 2007-06-25 Clasado Inc Nova composição de galacto-oligossacáridos e sua preparação.
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
GB0522740D0 (en) * 2005-11-08 2005-12-14 Clasado Inc Process for the production of oligosaccharides
GB0525857D0 (en) * 2005-12-20 2006-02-01 Product and process
EP1803358A1 (en) 2005-12-28 2007-07-04 Laboratorios Ordesa, S.L Infant immunological formula
GB0601901D0 (en) * 2006-01-31 2006-03-08 Product and Process
EP1988786B2 (en) † 2006-02-10 2019-10-09 Société des Produits Nestlé S.A. Oligosaccharide mixture
GB0606112D0 (en) 2006-03-28 2006-05-03 Product and process
FR2900029B1 (fr) * 2006-04-25 2012-09-14 Bel Fromageries Procede d'aromatisation de produits fromagers.
EP1887017A1 (en) * 2006-08-09 2008-02-13 Friesland Brands B.V. Prebiotic carbohydrate
SI2076271T1 (sl) * 2006-10-02 2011-12-30 Friesland Brands Bv Inhibicija toksinov kolere z galatooligosaharidi (GOS)
EP1988096A1 (en) * 2007-04-26 2008-11-05 Laboratorios Ordesa, S.L Process for preparing a galactooligosaccharides powder
WO2009113030A2 (en) * 2008-03-12 2009-09-17 Tata Chemicals Ltd. Process for the production of galactooligosaccharides by free cells
GB0809921D0 (en) * 2008-05-30 2008-07-09 Clasado Inc Product and process therefor
US20090297660A1 (en) * 2008-06-02 2009-12-03 Kraft Food Holdings, Inc. Cheese Products Containing Galacto-Oligosaccharides And Having Reduced Lactose Levels
BRPI1008280A2 (pt) 2009-02-24 2015-08-25 Ritter Pharmaceuticals Inc Formulações prebióticas e métodos mde uso
KR101121161B1 (ko) * 2009-02-24 2012-03-19 주식회사 제노포커스 고당전이 활성의 신규한 베타-갈락토시다제 및 그 용도
NZ595174A (en) * 2009-03-13 2013-04-26 Univ California Prebiotic galacto oligosaccharides used to stimulate growth or colonisation of beneficial bifidobacterium bacteria in gut
GB0906983D0 (en) * 2009-04-23 2009-06-03 Clasado Inc Novel use
UA104469C2 (uk) * 2009-05-27 2014-02-10 Класадо Інк. Спосіб запобігання діареї мандрівників
TWI446914B (zh) * 2009-06-04 2014-08-01 Clasado Inc 製備預防旅人腹瀉發生藥物之組成物之用途
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
IT1395068B1 (it) 2009-08-07 2012-09-05 Inalco Spa Processo per la produzione di galatto-oligosaccaridi ultrapuri
WO2011093907A1 (en) * 2010-02-01 2011-08-04 Corn Products International, Inc. High-purity galactooligosaccharides and uses thereof
EP2563372A4 (en) 2010-04-28 2013-10-02 Ritter Pharmaceuticals Inc PREBIOTIC FORMULATIONS AND METHODS OF USE
IL206678A0 (en) 2010-06-28 2010-12-30 Hcl Cleantech Ltd A method for the production of fermentable sugars
EA201300150A1 (ru) * 2010-07-19 2013-08-30 Арла Фудс Амба Способ изготовления продукта, содержащего галактоолигосахарид, и полученный на основе способа продукт
JP2017018135A (ja) * 2010-07-19 2017-01-26 アルラ フーズ アムバＡｒｌａ Ｆｏｏｄｓ Ａｍｂａ ガラクトオリゴ糖含有組成物およびそれを生産する方法
PL2481299T3 (pl) * 2011-01-31 2017-09-29 Synformulas Gmbh Szczepy bifidobacterium bifidum do stosowania w chorobach przewodu pokarmowego
GB2492559B (en) * 2011-07-05 2018-07-25 Clasado Inc Composition and method for preventing or reducing the risk of developing a syndrome
US11446316B2 (en) 2011-07-22 2022-09-20 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
JP5980785B2 (ja) * 2011-09-08 2016-08-31 株式会社ヤクルト本社 新規ビフィズス菌及びその利用
WO2013055785A1 (en) 2011-10-10 2013-04-18 Virdia Ltd Sugar compositions
ES2601891T3 (es) * 2011-10-18 2017-02-16 Nestec S.A. Composición para su uso en crecimiento cerebral y/o desarrollo cognitivo y/o psicomotor
GB2511993B (en) * 2011-11-30 2019-09-18 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
US8894771B2 (en) 2011-12-30 2014-11-25 Renmatix, Inc. Compositions comprising C5 and C6 monosaccharides
JP2015507011A (ja) * 2012-02-14 2015-03-05 ザ プロクター アンド ギャンブルカンパニー 皮膚共生プレバイオティック剤及びそれを含有する組成物の局所使用
GB201305708D0 (en) 2013-03-28 2013-05-15 Clasado Inc Novel use
US11116235B2 (en) 2013-05-24 2021-09-14 General Mills, Inc. Food products with yogurt whey
WO2015011276A1 (en) * 2013-07-26 2015-01-29 Novozymes A/S POLYPEPTIDES HAVING α-L-GALACTOSIDASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME
WO2015031176A1 (en) * 2013-08-30 2015-03-05 Abbott Laboratories Oral rehydration compositions with galactooligosaccharides
GB201319531D0 (en) * 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition & methods of screening
WO2015095747A1 (en) 2013-12-20 2015-06-25 Abbott Laboratories Oral rehydration composition with oligosaccharides
PL2896628T3 (pl) 2014-01-20 2019-03-29 Jennewein Biotechnologie Gmbh Sposób wydajnego oczyszczania obojętnych oligosacharydów ludzkiego mleka (HMO) z fermentacji mikrobiologicznej
CA3228982A1 (en) 2014-07-09 2016-01-14 Dsm Nutritional Products, Llc Oligosaccharide compositions and methods for producing thereof
WO2016080448A1 (ja) * 2014-11-19 2016-05-26 株式会社ヤクルト本社 セリアック病予防治療剤
CN112226466A (zh) 2015-01-07 2021-01-15 威尔迪亚公司 萃取和转化半纤维素糖的方法
WO2016122887A1 (en) 2015-01-26 2016-08-04 Midori Usa, Inc. Oligosaccharide compositions for use animal feed and methods of producing thereof
SI3354282T1 (sl) 2015-01-26 2021-07-30 Kaleido Biosciences, Inc. Glikanski terapevtiki in z njimi povezani postopki
EP3285777B1 (en) 2015-04-23 2021-06-09 Kaleido Biosciences, Inc. Glycan therapeutics and methods of treatment
EP3303639B1 (en) 2015-05-27 2020-08-05 Virdia, Inc. Integrated methods for treating lignocellulosic material
US10190142B2 (en) 2016-01-25 2019-01-29 King-Prebiotics Biotechnology (Tw) Co., Ltd. High-purity galactooligosaccharide compositions, preparations, and applications thereof
US10973245B2 (en) * 2016-06-24 2021-04-13 Yessinergy Holding S/A Immunomodulatory and growth promoting and controlling composition of intestinal microbiota undesirable bacteria and its use
JP2020513410A (ja) 2016-12-06 2020-05-14 カレイド・バイオサイエンシズ・インコーポレイテッド グリカンポリマーおよびその関連方法
KR101955251B1 (ko) 2017-07-31 2019-03-08 최승오 독서대 겸용 얼굴베개
EP3703705B1 (en) 2017-11-03 2024-05-15 DSM Nutritional Products, LLC Glucose-containing glycan preparations for use in the treatment of hyperammonaemia
CN111417398A (zh) 2017-11-03 2020-07-14 卡莱多生物科技有限公司 用于治疗感染的聚糖制剂
WO2020097568A2 (en) 2018-11-08 2020-05-14 Kaleido Biosciences, Inc. Oligosaccharide compositions and methods of use thereof
TW202103583A (zh) * 2019-03-29 2021-02-01 日商養樂多本社股份有限公司 源自飲食之高多醣利用性之新穎雙叉桿菌屬細菌
BR112021022447A2 (pt) * 2019-05-15 2021-12-28 Nutricia Nv Métodos para aumentar a função da barreira intestinal e/ou para a prevenção e/ou o tratamento de ruptura da barreira intestinal, método para o tratamento, a prevenção e/ou o alívio de uma condição associado à exposição a toxinas, fórmula infantil, fórmula de seguimento ou fórmula para criança de primeira infância, trissacarídeos, composições nutricionais, uso do trissacarídeo e usos de uma composição nutricional
AU2022302375A1 (en) * 2021-07-01 2024-02-01 N.V. Nutricia Nutritonal compositions for gut barrier function
GB202200069D0 (en) * 2022-01-05 2022-02-16 Vemico Ltd Compositions and methods for immunomodulation via control of intestinal microbiome
GB2619977A (en) * 2022-06-24 2023-12-27 Clasado Res Services Limited Compositions and uses thereof
GB2623336A (en) * 2022-10-12 2024-04-17 Clasado Res Services Limited Compositions and uses thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435389A (en) * 1980-07-07 1984-03-06 Kabushiki Kaisha Yakult Honsha Composition for promoting growth of bifidobacteria
JPS6259290A (ja) 1985-09-09 1987-03-14 Riyoushiyoku Kenkyukai イソラフイノ−ス及びその製造方法
JP2711095B2 (ja) * 1986-09-27 1998-02-10 ユニチカ株式会社 ビフイドバクテリウム菌の増殖促進剤の製造法
DK199887D0 (da) 1987-04-15 1987-04-15 Danisco Bioteknologi As Gaerstamme
JP2518663B2 (ja) * 1987-12-24 1996-07-24 株式会社ヤクルト本社 ガラクトオリゴ糖含有加工乳の製造法
US5149640A (en) * 1988-12-22 1992-09-22 Ajinomoto Co., Inc. Method for producing galactose transfer products
JP2819313B2 (ja) 1989-07-18 1998-10-30 焼津水産化学工業株式会社 Ｎ―アセチルラクトサミンの製造方法
JP2819312B2 (ja) 1989-07-18 1998-10-30 焼津水産化学工業株式会社 Ｎ―アセチルラクトサミンの製造法
CA2027835A1 (en) 1990-01-19 1991-07-20 William D. Prevatt Strains of phaffia rhodozyma containing high levels of astaxanthin
JP2750767B2 (ja) 1990-02-21 1998-05-13 雪印乳業株式会社 新規糖アルコール
JP2952439B2 (ja) 1991-11-26 1999-09-27 株式会社ホーネンコーポレーション 新規飲食品素材
JPH05146296A (ja) 1991-11-27 1993-06-15 Yakult Honsha Co Ltd β−ガラクトシダーゼ遺伝子を含むＤＮＡ断片及び該ＤＮＡ断片を組み込んだプラスミド
JP2904687B2 (ja) 1993-09-17 1999-06-14 雪印乳業株式会社 新規オリゴ糖
FR2723963B1 (fr) 1994-08-31 1997-01-17 Gervais Danone Co Preparation de produits fermentes par streptococcus thermophilus, enrichis en galacto-oligosaccharides et en beta-galactosidase
JP3246296B2 (ja) 1995-11-09 2002-01-15 宇部興産株式会社 半溶融金属の成形方法
JPH1023898A (ja) 1996-07-10 1998-01-27 Meiji Milk Prod Co Ltd Ｎ−アセチルラクトサミン誘導体の新規な製造法
KR100245383B1 (ko) 1996-09-13 2000-03-02 정훈보 교차홈 형성 전열관 및 그 제조 방법
JP2894293B2 (ja) 1996-09-17 1999-05-24 不二製油株式会社 ガラクタナーゼｓ−３９及びこれを産生するバチルスエスピーｓ−３９
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
JP3049693B1 (ja) 1998-12-10 2000-06-05 ソフィアインターナショナル株式会社 端末ターミナル
FR2789086B1 (fr) 1999-02-03 2003-01-31 Alain Rambach Procede de detection de bacteries cultivees en condition anaerobie
AU6206801A (en) * 2000-05-26 2001-12-03 Arla Foods Amba A new enzyme isolated from a bifidobacterium
EP1227152A1 (en) 2001-01-30 2002-07-31 Société des Produits Nestlé S.A. Bacterial strain and genome of bifidobacterium
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
GB0303716D0 (en) 2003-02-18 2003-03-19 Mars Uk Ltd Food product and process
PT1644482E (pt) * 2003-06-30 2007-06-25 Clasado Inc Nova composição de galacto-oligossacáridos e sua preparação.

Also Published As

Publication number Publication date
DE602004006133T3 (de) 2014-12-24
US20070274955A1 (en) 2007-11-29
CA2520043C (en) 2009-09-01
PL1644482T3 (pl) 2007-09-28
JP4384656B2 (ja) 2009-12-16
BRPI0408911B1 (pt) 2016-07-26
EP1644482A1 (en) 2006-04-12
JP4932874B2 (ja) 2012-05-16
PL1644482T5 (pl) 2015-05-29
ES2284028T3 (es) 2007-11-01
JP2007527199A (ja) 2007-09-27
RU2005129997A (ru) 2006-06-10
GB2412380A (en) 2005-09-28
DK1644482T4 (da) 2014-12-15
ATE360682T1 (de) 2007-05-15
MXPA05010349A (es) 2006-03-08
IL172553A (en) 2010-06-30
BRPI0408911A (pt) 2006-03-28
ES2284028T5 (es) 2014-12-04
PT1644482E (pt) 2007-06-25
HK1077323A1 (en) 2006-02-10
DE602004006133T2 (de) 2007-11-22
DK1644482T3 (da) 2007-08-13
CA2520043A1 (en) 2005-01-13
EP1644482B1 (en) 2007-04-25
RU2313572C2 (ru) 2007-12-27
NZ542482A (en) 2008-05-30
KR20050111624A (ko) 2005-11-25
AU2004254110A1 (en) 2005-01-13
WO2005003329A1 (en) 2005-01-13
NO20056004L (no) 2006-01-03
AU2004254110B2 (en) 2007-01-04
EP1644482B2 (en) 2014-10-01
EP1644482B8 (en) 2007-10-03
US7883874B2 (en) 2011-02-08
GB0513376D0 (en) 2005-08-03
GB2412380B (en) 2005-11-09
IL172553A0 (en) 2006-04-10
DE602004006133D1 (de) 2007-06-06
JP2009189374A (ja) 2009-08-27
NO335413B1 (no) 2014-12-08
KR100857500B1 (ko) 2008-09-08

Similar Documents

Publication Publication Date Title
CY1107671T1 (el) Νεα συνθεση γαλακτοολιγοσακχαριτη και η παρασκευη της
HUP0301939A2 (hu) Új probiotikumok hobbiállat-eledel kompozíciókhoz
CY1111124T1 (el) Βητα-γαλακτοζιδαση με διαγαλακτοζυλιωτικη δραστηριοτητα
DE60133581D1 (de) Von lactobacillus casei ke01 stamm abgeleitete probiotische verbindungen
MX2007004880A (es) Cepas de streptococcus thermophilus deficientes en aminopterina, con post-acidificacion reducida.
CY1111684T1 (el) ΓΑΛΑΚΤΟΣΙΔΑΣΗ ΜΕ ΕΝΕΡΓΟΤΗΤΑ α-ΓΑΛΑΚΤΟΖΥΛΟΜΕΤΑΦΟΡΑΣΗΣ
MY144029A (en) Alpha-galactosidase from bifidobacterium bifidum and its use
FI20002445A0 (fi) Menetelmä bakteerien seulomiseksi
ATE435595T1 (de) Tafeloliven, die probiotische mikroorganismen enthalten
GEU20061256Y (en) Yoghurt
RU2003112420A (ru) Биопрепарат лечебно-профилактического действия при эндометритах животных